↓ Skip to main content

Atypical antipsychotics for people with both schizophrenia and depression

Overview of attention for article published in Cochrane database of systematic reviews, January 2008
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

policy
1 policy source
twitter
7 X users

Citations

dimensions_citation
22 Dimensions

Readers on

mendeley
109 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Atypical antipsychotics for people with both schizophrenia and depression
Published in
Cochrane database of systematic reviews, January 2008
DOI 10.1002/14651858.cd005377.pub2
Pubmed ID
Authors

Vivek A Furtado, Vinod Srihari, Ajit Kumar

Abstract

Many people (up to 50%) with schizophrenia also have co-morbid depression. It has been suggested that new atypical antipsychotic drugs are beneficial for people with the two diagnoses.

X Demographics

X Demographics

The data shown below were collected from the profiles of 7 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 109 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Chile 1 <1%
Unknown 108 99%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 12 11%
Student > Ph. D. Student 11 10%
Researcher 11 10%
Student > Doctoral Student 10 9%
Student > Master 9 8%
Other 19 17%
Unknown 37 34%
Readers by discipline Count As %
Medicine and Dentistry 36 33%
Psychology 9 8%
Neuroscience 5 5%
Nursing and Health Professions 4 4%
Pharmacology, Toxicology and Pharmaceutical Science 4 4%
Other 8 7%
Unknown 43 39%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 August 2016.
All research outputs
#5,249,856
of 25,604,262 outputs
Outputs from Cochrane database of systematic reviews
#7,513
of 13,148 outputs
Outputs of similar age
#23,792
of 169,287 outputs
Outputs of similar age from Cochrane database of systematic reviews
#38
of 80 outputs
Altmetric has tracked 25,604,262 research outputs across all sources so far. Compared to these this one has done well and is in the 79th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 13,148 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 35.7. This one is in the 42nd percentile – i.e., 42% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 169,287 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 80 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.